Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.080 | 16 | 73035989 | intron variant | T/C | snv | 0.18 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 16 | 72959537 | synonymous variant | G/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2008 | 2008 | ||||||||
|
0.925 | 0.080 | 16 | 72959537 | synonymous variant | G/A | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2008 | 2008 | ||||||||
|
0.851 | 0.080 | 16 | 72958864 | missense variant | T/C;G | snv | 1.2E-05; 7.1E-02 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.080 | 16 | 72958864 | missense variant | T/C;G | snv | 1.2E-05; 7.1E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.080 | 16 | 72958864 | missense variant | T/C;G | snv | 1.2E-05; 7.1E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.080 | 16 | 72958864 | missense variant | T/C;G | snv | 1.2E-05; 7.1E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.763 | 0.160 | 16 | 73017721 | intron variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.763 | 0.160 | 16 | 73017721 | intron variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.763 | 0.160 | 16 | 73017721 | intron variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.763 | 0.160 | 16 | 73017721 | intron variant | C/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.763 | 0.160 | 16 | 73017721 | intron variant | C/G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.763 | 0.160 | 16 | 73017721 | intron variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.763 | 0.160 | 16 | 73017721 | intron variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.763 | 0.160 | 16 | 73017721 | intron variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.763 | 0.160 | 16 | 73017721 | intron variant | C/G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.763 | 0.160 | 16 | 73017721 | intron variant | C/G;T | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.080 | 16 | 72945475 | intron variant | C/T | snv | 0.51 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.080 | 16 | 73034779 | intron variant | G/A | snv | 0.17 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2020 | 2020 | |||||||
|
16 | 72962263 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 3 | 2017 | 2019 | |||||||||||
|
1.000 | 0.120 | 16 | 72990377 | intron variant | C/T | snv | 0.28 |
|
0.700 | 1.000 | 2 | 2019 | 2019 | ||||||||
|
1.000 | 0.080 | 16 | 73019123 | intron variant | T/A | snv | 0.21 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.700 | 1.000 | 2 | 2018 | 2018 | |||||||
|
16 | 73392991 | intron variant | C/T | snv | 9.6E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
16 | 73346464 | intron variant | C/T | snv | 0.18 |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
16 | 72925068 | intron variant | C/T | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2019 | 2019 |